Common Stock, Shares, Outstanding of Gain Therapeutics, Inc. from 31 Dec 2020 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Gain Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2020 to 30 Sep 2025.
  • Gain Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 35,976,390, a 39% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Gain Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 35,976,390 +10,014,144 +39% 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 30,771,321 +5,598,748 +22% 30 Jun 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 28,746,041 +10,704,810 +59% 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 27,132,588 +10,925,908 +67% 31 Dec 2024 10-Q 12 Nov 2025 2025 Q3
Q3 2024 25,962,246 +13,179,385 +103% 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 25,172,573 +12,540,246 +99% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 18,041,231 +5,954,089 +49% 31 Mar 2024 10-Q 14 May 2024 2024 Q1
Q4 2023 16,206,680 +4,323,312 +36% 31 Dec 2023 10-K 27 Mar 2025 2024 FY
Q3 2023 12,782,861 +899,493 +7.6% 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 12,632,327 +748,959 +6.3% 30 Jun 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 12,087,142 +203,774 +1.7% 31 Mar 2023 10-Q 12 May 2023 2023 Q1
Q4 2022 11,883,368 0 0% 31 Dec 2022 10-K 26 Mar 2024 2023 FY
Q3 2022 11,883,368 +3,625 +0.03% 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 11,883,368 +6,908 +0.06% 30 Jun 2022 10-Q 08 Aug 2022 2022 Q2
Q1 2022 11,883,368 +6,908 +0.06% 31 Mar 2022 10-Q 16 May 2022 2022 Q1
Q4 2021 11,883,368 +8,340,205 +235% 31 Dec 2021 10-K 23 Mar 2023 2022 FY
Q3 2021 11,879,743 30 Sep 2021 10-Q 12 Nov 2021 2021 Q3
Q2 2021 11,876,460 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 11,876,460 31 Mar 2021 10-Q 10 May 2021 2021 Q1
Q4 2020 3,543,163 31 Dec 2020 10-K 25 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.